Klein NP, Peyrani P, Yacisin K, Caldwell N, et al. A phase 3, randomized, double-blind study to evaluate the immunogenicity and safety of 3 lots of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults 18 through 49 years of age. Vaccine 2021 Jul 24. pii: S0264-410X(21)00863.
PMID: 34315611